NTRK3 and non-small cell lung carcinoma: The 11 currently reportable or Tier 1/actionable variants for NSCLC (ALK, EGFR, BRAF, KRAS, NTRK1, NTRK2, NTRK3, ROS, RET, MET and ERBB2) were verified and commercial control material was utilised to supplement the verification.